Shuren: Time to rethink FDA's device regulatory framework
Regulatory NewsJeff Craven
Clinical TrialsCombination products/companion diagnosticsMedical DevicesProduct LifecycleRegulatory NewsJeff CravenClinical TrialsCombination products/companion diagnosticsMedical DevicesProduct Lifecycle